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Identity 
Other names: ER1, Er1, KIAA1610, MGC150641, 
MGC131940, MGC150640, MI-ER1, hMI-ER1, RP5-
944N15.1, DKFZp781G0451 




MIER1 was identified by differential display as an 
immediate-early gene activated during fibroblast 
growth factor (FGF) induction of mesoderm 
differentiation in Xenopus laevis. 
DNA/RNA 
 
A. Schematic illustrating the exon-intron organizat ion of the human MIER1 gene.  Exons are shown as red bars/vertical lines and 
introns as horizontal lines; exon numbers are indicated below each schematic. The light red bar indicates the facultative intron 16 and the 
position of the alpha and beta carboxy-terminal coding regions are indicated. Note that the beta coding region is located within the 
facultative intron. The three alternate starts of translation, ML-, MF- and MAE- are indicated as are the three polyadenylation signals 
(PAS): i, ii and iii. 
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B. Schematic illustrating the variant 5' and 3' end s of human MIER1 transcripts.  Alternate 5' ends are generated from differential 
promoter usage (P1 or P2) or alternate inclusion of exon 3A. This leads to three alternate starts of translation, indicated as ML-, MF- and 
MAE-, and produces three distinct amino termini. The four variant 3' ends, a, bi, bii and biii, produced by alternative splicing or alternate 
PAS usage, result in transcripts readily distinguished by size (1.7 kb, 2.5 kb, 3.4 kb and 4.8 kb, respectively) on a Northern blot. It should 
be noted that three of the variant 3' ends, bi, bii and biii encode the same protein sequence and differ only in their untranslated region. * 
indicates beta encoding transcript that contains the alpha exon in its 3'UTR. The locations of the alpha and beta carboxy-terminal coding 
regions and PAS i, ii and iii are indicated. The combination of three possible 5' ends with four possible 3' ends gives rise to 12 distinct 
transcripts, but only 6 distinct protein isoforms. In most adult tissues, the most abundant transcript is 4.8 kb. Additional transcripts have 




63 kb gene; 2 promoters controlling 2 distinct 
transcriptional start sites; 17 exons; intron 16 is 
facultative; 3 polyadenylation sites. 
Protein 
Description 
The six human MIER1 isoforms: M-3A-alpha (457 aa), 
M-3A-beta (536 aa), ML-alpha (432 aa), ML-beta (511 
aa), MAE-alpha (433 aa), and MAE-beta (512 aa), 
range in predicted molecular size from 47.5 kDa-59 
kDa; however all isoforms migrate slower than 
predicted on SDS-PAGE, with calculated molecular 
sizes ranging 78 kDa-90 kDa. 
Expression 
MIER1beta protein is expressed ubiquitously, while 
MIER1alpha protein is expressed mainly in a subset of 
endocrine organs and endocrine responsive tissues, 
including the pancreatic islets, adrenal glands, tetis, 
ovary, hypothalamus, pituitary, parafollicular cells of 
the thyroid and mammary ductal epithelium. 
Localisation 
MIER1beta is nuclear in all adult cell types but is 
retained in the cytoplasm of the pre-gastrula Xenopus 
embryo. MIER1alpha is cytoplasmic in most cell types, 
but localized in the nucleus in normal mammary ductal 
epithelium. During progression to invasive breast 
carcinoma, its subcellular localization shifts from 
nuclear to exclusively cytoplasmic. 
Function 
MIER1alpha and beta function in transcriptional 
repression by at least two distinct mechanisms: 
recruitment and regulation of chromatin modifying 
enzymes, including HDAC1, HDAC2, CBP and G9a; 
interaction with transcription factors, such as Sp1 and 
ERalpha, to repress transcription of their respectiv  
target genes. MIER1alpha inhibits estrogen-stimulated 
anchorage-independent growth of breast carcinoma 
cells. 
Homology 
The MIER1 gene family contains two other members, 
MIER2 and MIER3. The MIER1 gene is conserved in 
chimpanzee, dog, cow, mouse, rat, chicken, frog, 
zebrafish, fruit fly, and C. elegans. 
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Schematic illustrating the common internal domains of the MIER1 isoforms and the variant amino- (N-) a nd carboxy- (C-) 
termini.  Transcription from the P1 promoter produces proteins that either begin with M-L- or with the sequence encoded by exon 3A 
(MFMFNWFTDCLWTLFLSNYQ). Transcription from the P2 promoter produces a protein that begins with M-A-E-. The variant N-termini 
of the MIER1 isoforms are followed by common internal sequence containing several distinct domains: acidic, which function in 
transcriptional activation (Paterno et al., 1997); ELM2, responsible for recruitment of HDAC1 (Ding et al., 2003); SANT, which interacts 
with Sp1 (Ding et al., 2004) and PSPPP, which is required for MIER1 activity in the Xenopus embryo (Teplitsky et al., 2003). The two 
alternate C-termini, alpha and beta, result from removal or inclusion and read-through of intron 16, respectively. The alpha C-terminus 





Initial studies showed that total MIER1 mRNA levels 
were increased in breast carcinoma cell lines and 
tumour samples (Paterno et al., 1998); in a more rec nt 
study, no consistent difference in MIER1alpha protein 
expression levels between normal breast and tumour 
samples was detected (McCarthy et al., 2008). 
Immunohistochemical analysis of patient biopsies 
revealed that MIER1alpha protein is expressed 
primarily in ductal epithelial cells in normal breast 
tissue, with little or no expression in the surrounding 
stroma; in breast carcinoma samples, its expression i  
restricted to tumour cells. While there is no difference 
in expression levels, the subcellular localization f 
MIER1alpha changes dramatically during tumour 
progression: MIER1alpha is nuclear in 75% of normal 
breast samples and in 77% of hyperplasia, but in breast 
carcinoma, only 51% of ductal carcinoma in situ, 25% 
of invasive lobular carcinoma and 4% of invasive 
ductal carcinoma contained nuclear MIER1alpha 
(McCarthy et al., 2008). This shift from nuclear to 
cytoplasmic localization of MIER1alpha during breast 
cancer progression suggests that loss of nuclear 
MIER1alpha contributes to the development of 
invasive breast carcinoma. MIER1alpha inhibits 
ERalpha transcriptional activity and overexpression of 
MIER1alpha in breast carcinoma cells inhibits 
estrogen-stimulated anchorage-independent growth 
(McCarthy et al., 2008). 
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